Globe Newswire08.14.20
WishBone Medical Inc., a leader in pediatric orthopedic medical devices, has appointed Jeff George, global healthcare executive and investor, to the company’s board of directors, effective Aug. 12.
“As WishBone takes on more opportunities and acquisitions, it is important to add expertise and capital, of which Jeff George provides both,” said Nick Deeter, founder, chairman, and CEO of WishBone Medical. “Emerging growth companies like ours go through numerous phases in their development. Jeff is an extremely important addition to the board. He will help WishBone to implement the plan and become the undisputed leader in pediatric orthopedics. WishBone has moved at light speed to raise standards for the 95 percent* of children who still receive adult implants that are not FDA-cleared for pediatric use. As the first and only pediatric orthopedic company operating with a 'single-use' business model, we’re on track to fully mitigate this issue once and for all.”
George is currently managing partner of Maytal Capital, a healthcare-focused private equity and venture capital investment and advisory firm he founded in 2017, and an operating partner at Revival Healthcare Capital, a medical device-focused private equity firm based in Texas. He serves on the Board of Directors at Amneal Pharmaeuticals, a specialty and generic pharmaceuticals company, and at Roam Analytics, a Silicon Valley-based artificial intelligence healthcare software firm. From 2008 to 2016, George served on the Executive Committee of Switzerland-based Novartis Group AG, one of the world's largest pharmaceutical companies, where he served as division head and CEO of Sandoz, Novartis’s $10 billion generic pharmaceuticals and biosimilars subsidiary headquartered in Munich, Germany, and then as division head and CEO of Texas-based Alcon, Novartis’s then $10 billion eyecare subsidiary.
“WishBone is an exciting, mission-driven, and rapidly-growing leader in pediatric orthopedics, and I am honored to join the Board,” said George. “Spending time with Nick and his leadership team the past year has given me strong conviction that WishBone is poised for continued break-out growth as we work to meet the significant unmet need for kids in this important field. I look forward to partnering with Nick and the Board to support WishBone as it scales in the US and globally.”
George earned an MBA from Harvard Business School and a master’s degree from Johns Hopkins University’s School of Advanced International Studies (SAIS), where he studied international economics and emerging markets political economy. He earned a bachelor of arts degree in international relations, magna cum laude and Phi Beta Kappa, from Carleton College. An active volunteer, George also serves on the board of directors for several non-profit organizations, including Education Opens Doors (where he is chairman), the North Texas Food Bank, and the Young Presidents’ Organization (YPO) of Dallas. He previously served on the Board of Directors for AdvaMed, the medical device industry association. Both he and Maytal Capital are based in Dallas.
* Data on file.
“As WishBone takes on more opportunities and acquisitions, it is important to add expertise and capital, of which Jeff George provides both,” said Nick Deeter, founder, chairman, and CEO of WishBone Medical. “Emerging growth companies like ours go through numerous phases in their development. Jeff is an extremely important addition to the board. He will help WishBone to implement the plan and become the undisputed leader in pediatric orthopedics. WishBone has moved at light speed to raise standards for the 95 percent* of children who still receive adult implants that are not FDA-cleared for pediatric use. As the first and only pediatric orthopedic company operating with a 'single-use' business model, we’re on track to fully mitigate this issue once and for all.”
George is currently managing partner of Maytal Capital, a healthcare-focused private equity and venture capital investment and advisory firm he founded in 2017, and an operating partner at Revival Healthcare Capital, a medical device-focused private equity firm based in Texas. He serves on the Board of Directors at Amneal Pharmaeuticals, a specialty and generic pharmaceuticals company, and at Roam Analytics, a Silicon Valley-based artificial intelligence healthcare software firm. From 2008 to 2016, George served on the Executive Committee of Switzerland-based Novartis Group AG, one of the world's largest pharmaceutical companies, where he served as division head and CEO of Sandoz, Novartis’s $10 billion generic pharmaceuticals and biosimilars subsidiary headquartered in Munich, Germany, and then as division head and CEO of Texas-based Alcon, Novartis’s then $10 billion eyecare subsidiary.
“WishBone is an exciting, mission-driven, and rapidly-growing leader in pediatric orthopedics, and I am honored to join the Board,” said George. “Spending time with Nick and his leadership team the past year has given me strong conviction that WishBone is poised for continued break-out growth as we work to meet the significant unmet need for kids in this important field. I look forward to partnering with Nick and the Board to support WishBone as it scales in the US and globally.”
George earned an MBA from Harvard Business School and a master’s degree from Johns Hopkins University’s School of Advanced International Studies (SAIS), where he studied international economics and emerging markets political economy. He earned a bachelor of arts degree in international relations, magna cum laude and Phi Beta Kappa, from Carleton College. An active volunteer, George also serves on the board of directors for several non-profit organizations, including Education Opens Doors (where he is chairman), the North Texas Food Bank, and the Young Presidents’ Organization (YPO) of Dallas. He previously served on the Board of Directors for AdvaMed, the medical device industry association. Both he and Maytal Capital are based in Dallas.
* Data on file.